{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:32:50Z","timestamp":1790163170630,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Damial Foundation"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ebiom.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T04:13:23Z","timestamp":1517631203000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"special_numbering":"C","title":["Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Violaine K.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6583-4677","authenticated-orcid":false,"given":"Tamara","family":"Vyshkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Blackshear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Stefanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud A.","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2018.02.002_bb0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1089\/scd.2016.0020","article-title":"Mesenchymal stromal\/stem cells do not ameliorate experimental autoimmune encephalomyelitis and are not detectable in the central nervous system of transplanted mice","volume":"25","author":"Abramowski","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0010","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nn.3109","article-title":"Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models","volume":"15","author":"Bai","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/157488812804484648","article-title":"Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study","volume":"7","author":"Bonab","year":"2012","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00557-3","article-title":"Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats","volume":"189","author":"Chen","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0025","article-title":"Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis","author":"Cohen","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(16)32388-1","article-title":"Evolving concepts in the treatment of relapsing multiple sclerosis","volume":"389","author":"Comi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0040","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1089\/scd.2010.0547","article-title":"Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice","volume":"20","author":"Cristofanilli","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0045","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1523\/JNEUROSCI.3803-11.2012","article-title":"Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination","volume":"32","author":"Deverman","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing","volume":"14","author":"Francois","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/scd.2008.0068","article-title":"Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population","volume":"17","author":"Fu","year":"2008","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.21076","article-title":"Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis","volume":"61","author":"Gerdoni","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.expneurol.2011.02.021","article-title":"Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis","volume":"230","author":"Grigoriadis","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5966\/sctm.2012-0015","article-title":"Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis","volume":"1","author":"Harris","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2011.08.036","article-title":"Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis","volume":"313","author":"Harris","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0080","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jcyt.2016.08.007","article-title":"Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis","volume":"18","author":"Harris","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0085","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1242\/jcs.01307","article-title":"Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells","volume":"117","author":"Hermann","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.expneurol.2016.02.023","article-title":"The role of growth factors as a therapeutic approach to demyelinating disease","volume":"283","author":"Huang","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0095","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.65.6.753","article-title":"Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis","volume":"65","author":"Kassis","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.20126","article-title":"Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells","volume":"49","author":"Li","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113936","article-title":"Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis","volume":"9","author":"Llufriu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0120","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.exphem.2006.06.020","article-title":"Neural differentiation of human mesenchymal stem cells: evidence for expression of neural markers and eag K+ channel types","volume":"34","author":"Mareschi","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0125","series-title":"Aids to the Examination of the Peripheral Nervous System","author":"Medical Research Council","year":"2000"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","article-title":"Mechanisms involved in the therapeutic properties of mesenchymal stem cells","volume":"20","author":"Meirelles Lda","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0135","first-page":"50","article-title":"Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study","volume":"4","author":"Mohyeddin Bonab","year":"2007","journal-title":"Iran J. Immunol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0140","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5966\/sctm.2014-0212","article-title":"Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis","volume":"4","author":"Oh","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0150","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","article-title":"Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function","volume":"389","author":"Ontaneda","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0155","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3727\/096368912X657620","article-title":"Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination","volume":"22","author":"Payne","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0160","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/srep38743","article-title":"The secretome of periodontal ligament stem cells from MS patients protects against EAE","volume":"6","author":"Rajan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0170","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1634\/stemcells.2005-0614","article-title":"Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells","volume":"24","author":"Rivera","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/STROKEAHA.110.593863","article-title":"Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice","volume":"42","author":"Shen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0180","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000003359","article-title":"Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS","volume":"87","author":"Staff","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0185","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1089\/scd.2011.0137","article-title":"Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate","volume":"21","author":"Steffenhagen","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","article-title":"Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study","volume":"227","author":"Yamout","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0195","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jnr.20962","article-title":"Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice","volume":"84","author":"Zhang","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ebiom.2018.02.002_bb0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/14653240902806986","article-title":"Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"11","author":"Zhang","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0210","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/glia.20840","article-title":"GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons","volume":"57","author":"Zhang","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.ebiom.2018.02.002_bb0215","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/mabi.200700334","article-title":"Recruitment of endogenous stem cells for tissue repair","volume":"8","author":"Zhao","year":"2008","journal-title":"Macromol. Biosci."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418300513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418300513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:47:16Z","timestamp":1762454836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418300513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"alternative-id":["S2352396418300513"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.02.002","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}